SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma - Université de Rennes Access content directly
Journal Articles British Journal of Cancer Year : 2015

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

P. El Hajj
  • Function : Author
M. Migault
  • Function : Author
A. Theunis
  • Function : Author
L. C. Van Kempen
  • Function : Author
F. Salés
  • Function : Author
H. Fayyad-Kazan
  • Function : Author
B. Badran
  • Function : Author
A. Awada
  • Function : Author
L. Bachelot
  • Function : Author
G. Ghanem
  • Function : Author
F Journe
  • Function : Author

Abstract

BACKGROUND: We previously demonstrated an inverse correlation between tyrosinase-related protein 1 (TYRP1) mRNA expression in melanoma metastases and patient survival. However, TYRP1 protein was not detected in half of tissues expressing mRNA and did not correlate with survival. Based on a study reporting that 3' untranslated region (UTR) of TYRP1 mRNA contains two miR-155-5p (named miR-155) binding sites exhibiting single-nucleotide polymorphisms (SNPs) that promote (matched miRNA-mRNA interaction) mRNA decay or not (mismatched), we aimed to investigate the role of miR-155 in the regulation of TYRP1 mRNA expression and protein translation accounting for these SNPs. METHODS: The effect of miR-155 on TYRP1 mRNA/protein expression was evaluated in two melanoma cell lines harbouring matched or mismatched miR-155-TYRP1 mRNA interaction after transfection with pre-miR-155. In parallel, 192 skin and lymph node melanoma metastases were examined for TYRP1 mRNA/protein, miR-155 and SNPs and correlated with patient survival. TYRP1 mRNA, SNPs at its 3'UTR and miR-155 were analysed by RT-qPCR, whereas TYRP1 protein was evaluated by western blot in cell lines and by immunohistochemistry in metastatic tissues. RESULTS: The miR-155 induced a dose-dependent TYRP1 mRNA decay and hampered its translation into protein in the line with the 'match' genotype. In melanoma metastases, TYRP1 mRNA inversely correlated with miR-155 expression but not with TYRP1 protein in the 'match' group, whereas it positively correlated with protein but not with miR-155 in the 'mismatch' group. Consequently, in the latter group, TYRP1 protein inversely correlated with survival. CONCLUSION: Polymorphisms in 3'UTR of TYRP1 mRNA can affect TYRP1 mRNA regulation by miR-155 and its subsequent translation into protein. These SNPs can render TYRP1 mRNA and protein expression nonsusceptible to miR-155 activity and disclose a prognostic value for TYRP1 protein in a subgroup of melanoma patients. These data support the interest in the prognostic value of melanogenic markers and propose TYRP1 to refine prognosis in patients with advanced disease
Fichier principal
Vignette du fichier
bjc2015194.pdf (1.06 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-01175527 , version 1 (17-06-2022)

Identifiers

Cite

P. El Hajj, D. Gilot, M. Migault, A. Theunis, L. C. Van Kempen, et al.. SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma. British Journal of Cancer, 2015, 113 (1), pp.91--98. ⟨10.1038/bjc.2015.194⟩. ⟨hal-01175527⟩
60 View
29 Download

Altmetric

Share

Gmail Facebook X LinkedIn More